Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
95% Confidence Interval
15%
Acute Coronary Syndrome
16%
Acute Myeloblastic Leukemia
20%
Acute Myeloid Leukemia
14%
Alkylating Agents
15%
B-cell Lymphoma 2 (Bcl-2)
15%
Bone Marrow
26%
Breast Cancer
14%
Breast Cancer Cells
23%
Cancer in Pregnancy
25%
CD82
16%
Chemotherapy
45%
Chronic Lymphocytic Leukemia
60%
Chronic Myeloid Leukemia
39%
Doxorubicin
25%
During Pregnancy
100%
Enalapril
25%
Essential Thrombocythemia
18%
Fetal Outcome
20%
Fetus
26%
First Trimester
28%
Fluorescence in Situ Hybridization
63%
Hematological Malignancies
18%
Hodgkin Disease
16%
Human Mesenchymal Stem Cells (hMSCs)
17%
In Situ Hybridization
14%
Israel
15%
Leukemia
22%
Leukemia Patients
36%
Lymphoma
31%
Lymphoma Patients
33%
Malignancy
20%
Malignant Cells
16%
Malignant Melanoma
16%
Maternal Outcomes
15%
Mesenchymal Stem Cells
18%
Microvesicles
18%
Multiple Myeloma
88%
Myeloma
18%
Myeloma Cells
60%
Non-Hodgkin Lymphoma
45%
Non-pregnant Women
25%
Placenta
32%
Polycythemia Vera
18%
Pregnant Women
42%
Risk Factors
20%
Statins
20%
Supernatant
17%
Tetraspanin
32%
Trisomy 12
14%
Medicine and Dentistry
Acute Leukemia
12%
Antiphospholipid Syndrome
12%
B-Cell Chronic Lymphocytic Leukemia
35%
Biopsy Technique
15%
Breast Cancer
26%
Cancer
55%
Cardiovascular Disease
13%
Cervical Cancer
12%
Chemotherapy
78%
Cholesterol
11%
Chronic Myelogenous Leukemia
14%
Congenital Malformation
22%
Creatinine
14%
Cyclophosphamide
14%
Diabetes Mellitus
16%
Diseases
44%
Doxorubicin
29%
Enalapril
14%
First Trimester Pregnancy
28%
Fluorescence in Situ Hybridization
20%
Glucose
11%
Hematologic Malignancy
17%
Hodgkin's Lymphoma
33%
Ischemic Heart Disease
19%
Kidney Function
15%
Leukemia
19%
Leukocyte
11%
Lipid
14%
Low Density Lipoprotein Cholesterol
14%
Lymphocyte
11%
Magnetic Resonance Imaging
11%
Malignant Neoplasm
68%
Maturity Onset Diabetes of the Young
25%
Melanoma
14%
Microsatellite Instability
14%
Monoclonal Gammopathy of Undetermined Significance
14%
Motherisk
11%
Multiple Myeloma
35%
Neoplasm
16%
Nephropathy
16%
Non-Hodgkin Lymphoma
41%
Pathogenesis
11%
Patient with Non-Hodgkins Lymphoma
19%
Placebo
18%
Placenta
12%
Pregnancy Termination
16%
Pregnant Woman
21%
Prospective Study
12%
Second Cancer
12%
Venous Thromboembolism
12%